facebook pixel

Pipeline

Science is our passion. Helping people live healthier, more productive lives is our reward.

Explore our pipeline to view the clinical development programs. For more information about a program, please click on the name of the condition.

Catalyst Pharmaceuticals Pipeline

Pipeline FDA Approval Process

Indication

Pre-Clinical

Phase 1

Phase 2

Phase 3

FDA Review

Approval

FIRDAPSE® Pediatric Label 1,2,3
Lambert Eaton myasthenic syndrome
  • 100% 100%
FIRDAPSE® 100 mg Dose Expansion 1,2,3
Lambert Eaton myasthenic syndrome
  • 90% 90%

Vamorolone1,2,4
Duchenne muscular dystrophy

  • 100% 100%
1EAP=Expanded Access Program; ISI investigator Sponsored IND
2Orphan Drug Designation
3Breakthrough Therapy Designation
4Lead Indication